Penumbra, Inc. PEN 深 滬
等待開盤 03-26 09:30:00 美东时间
336.27
+2.100
+0.63%
華盛通- 最 高336.68
- 今 開336.68
- 成交量 37.27万股
- 最 低 335.06
- 昨 收 334.17
- 總市值 131.96亿
- 52周最高 362.41
- 市盈率 靜 74.36
- 換手率 0.95%
- 52周最低 221.26
- 委 比 42.86%
- 總股本 3924.31万
- 歷史最高 362.41
- 量 比 0.67
- 振 幅 0.48%
- 歷史最低 35.315
- 每 手 1
- 風險率 36.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多8 Stocks to Buy as Merger-Mania Takes Over
Consolidation wave creates opportunities for patient investors. 8 sectors leading now are health, semiconductors, medical devices, and media.
03-11 00:42
Penumbra CFO Maggie Yuen Disposes of Common Shares
Penumbra CFO Maggie Yuen Disposes of Common Shares Maggie Yuen, Chief Financial Officer of Penumbra Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generativ
03-05 08:32
Boston Scientific Corp Stock Moved Down by 3.32% on Mar 3: Facts Behind the Movement
• Boston Scientific faces recall of AXIOS Stent, triggering investigations. • $14.5 billion Penumbra acquisition adds debt and dilutes earnings. • Electrophysiology segment underperformed; sales guidance lowered.
03-03 17:15
美股大行评级 | 最高300美元！大摩、小摩、花旗纷纷上调英伟达目标价；赛富时、C3.ai、Snowflake、Trade Desk等遭数十家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从47美元升至49美元；Citizens：维持Ironwood医药"跑赢大市"评级，目标价从8美元升至10美元
02-27 11:07
Evercore ISI Group Maintains Outperform on Penumbra, Raises Price Target to $360
Evercore ISI Group analyst Vijay Kumar maintains Penumbra (NYSE:PEN) with a Outperform and raises the price target from $340 to $360.
02-26 23:42
财报速睇 | Penumbra, Inc. 2025财年年度营收14.04亿美元，同比增长17.5%；归母净利润1.78亿美元，同比增长1168.1%
华盛资讯2月26日讯，Penumbra, Inc.公布2025财年年度业绩，公司年度营收14.04亿美元，同比增长17.5%，归母净利润1.78亿美元，同比增长1168.1%。
02-26 02:50
财报速睇 | Penumbra, Inc. 2025财年Q4营收3.85亿美元，同比增长22.1%；归母净利润0.47亿美元，同比增长40.6%
华盛资讯2月26日讯，Penumbra, Inc.公布2025财年Q4业绩，公司Q4营收3.85亿美元，同比增长22.1%，归母净利润0.47亿美元，同比增长40.6%。
02-26 02:17
Penumbra Q4 Earnings Assessment
The earnings results for Penumbra (NYSE:PEN) for Q4 were made public on Wednesd...
02-26 02:04
Penumbra Q4 Adj. EPS $1.18 Beats $1.11 Estimate, Sales $385.385M Beat $366.795M Estimate
Penumbra (NYSE:PEN) reported quarterly earnings of $1.18 per share which beat the analyst consensus estimate of $1.11 by 6.12 percent. This is a 38.82 percent increase over earnings of $0.85 per share from the same
02-26 02:03
Boston Scientific shares slide on cautious 2026 revenue forecast
Boston Scientific shares slide on cautious 2026 revenue forecast Feb 4 (Reuters) - Boston Scientific Corp forecast modest 2026 revenue growth and profit just below Wall Street expectations on Wednesday, overshadowing a strong fourth-quarter performance and sending its shares down more than 11% in pr
02-04 20:54
